# DUSP21

## Overview
DUSP21 is a gene that encodes the protein dual specificity phosphatase 21, which belongs to the family of dual specificity phosphatases. These enzymes are characterized by their ability to dephosphorylate both phosphotyrosine and phosphoserine/threonine residues on target proteins, thus playing a role in the regulation of cellular signaling pathways. DUSP21 is predominantly expressed in the testis and is localized to the mitochondria, specifically the mitochondrial inner membrane, in healthy human cells (Rardin2008Dual). Although it can dephosphorylate synthetic MAPK peptides, its influence on MAPK activity in vivo appears limited, suggesting a context-dependent role in cellular signaling (Patterson2009Dualspecificity). The protein's precise physiological functions remain to be fully elucidated, but it has been implicated in cancer progression, particularly in hepatocellular carcinoma, where it may act as a pro-oncogenic factor (Gao2021The). Further research is necessary to understand the broader implications of DUSP21 in health and disease.

## Function
DUSP21, a dual specificity phosphatase, is involved in dephosphorylating both phosphotyrosine and phosphoserine/threonine residues on target proteins. In healthy human cells, DUSP21 is primarily expressed in the testis, where it localizes to the mitochondria, specifically the mitochondrial inner membrane, facing the matrix compartment. This localization is facilitated by an internal mitochondrial targeting signal within amino acids 43-128 (Rardin2008Dual). In COSM6 cells, exogenous DUSP21 is found in both the cytoplasm and nucleus, while in COS7 cells, endogenous DUSP21 is localized to the mitochondria (Patterson2009Dualspecificity).

Despite its ability to dephosphorylate synthetic MAPK peptides, DUSP21 does not appear to influence MAPK activity in vivo, suggesting its role in cellular signaling pathways may be limited or context-dependent (Patterson2009Dualspecificity). The physiological role of DUSP21 in healthy cells remains unclear, as its activity has not been shown to significantly impact known signaling pathways. Further research is needed to elucidate its specific functions and potential roles in cellular processes such as growth, differentiation, and stress response (Rardin2008Dual; Patterson2009Dualspecificity).

## Clinical Significance
DUSP21 is implicated in the progression of hepatocellular carcinoma (HCC), where it is upregulated and contributes to tumor cell proliferation, colony formation, and tumorigenicity. Silencing DUSP21 in HCC cells significantly inhibits these processes by activating the P38 MAPK pathway, suggesting a pro-oncogenic role for DUSP21 in cancer. Knockdown of DUSP21 also induces cell senescence, indicating its involvement in inhibiting cellular aging processes, which may further promote tumor growth (Gao2021The).

Alterations in DUSP21 expression have been observed in other cancer types, such as lymphoid neoplasm diffuse large B-cell lymphoma (DLBC) and thymoma (THYM). However, the precise roles of DUSP21 in these cancers remain unclear due to insufficient functional research. The variability in DUSP21's role across different cancers highlights the complexity of its function, with some dual-specificity phosphatases acting as tumor suppressors and others as promoters of cancer progression (Gao2021The).

The clinical significance of DUSP21, including its potential as a therapeutic target, requires further investigation to fully understand its role in cancer and other diseases (Gao2021The).


## References


[1. (Rardin2008Dual) Matthew J. Rardin, Sandra E. Wiley, Anne N. Murphy, David J. Pagliarini, and Jack E. Dixon. Dual specificity phosphatases 18 and 21 target to opposing sides of the mitochondrial inner membrane. Journal of Biological Chemistry, 283(22):15440–15450, May 2008. URL: http://dx.doi.org/10.1074/jbc.m709547200, doi:10.1074/jbc.m709547200. This article has 23 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m709547200)

[2. (Patterson2009Dualspecificity) Kate I. Patterson, Tilman Brummer, Philippa M. O’brien, and Roger J. Daly. Dual-specificity phosphatases: critical regulators with diverse cellular targets. Biochemical Journal, 418(3):475–489, February 2009. URL: http://dx.doi.org/10.1042/bj20082234, doi:10.1042/bj20082234. This article has 576 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1042/bj20082234)

[3. (Gao2021The) Ping-Ping Gao, Xiao-Wei Qi, Na Sun, Yuan-Yuan Sun, Ye Zhang, Xuan-Ni Tan, Jun Ding, Fei Han, and Yi Zhang. The emerging roles of dual-specificity phosphatases and their specific characteristics in human cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1876(1):188562, August 2021. URL: http://dx.doi.org/10.1016/j.bbcan.2021.188562, doi:10.1016/j.bbcan.2021.188562. This article has 19 citations.](https://doi.org/10.1016/j.bbcan.2021.188562)